Plain-English translation of NCT06060912 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether the LAmbre device works as well as the AMPLATZER Amulet device—two different implants that sit in a small pouch of your heart called the left atrial appendage. Both devices are designed to prevent blood clots and stroke in people with irregular heartbeat (atrial fibrillation) who cannot safely take blood-thinning medications long-term. Researchers want to know if the newer LAmbre device is just as effective as the more established AMPLATZER Amulet.
Many people with irregular heartbeat cannot take blood thinners due to allergies, bleeding risks, or other health conditions—even though they badly need protection against stroke. This trial exists to give doctors another proven option and help them choose the best device for each patient.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive one of the two devices through a minimally invasive procedure. After the device is implanted, you will take specific medications as instructed and attend follow-up visits to monitor how well the device is working—including an imaging test (echocardiogram) about 3 months after implantation. The study team will track your progress over time to compare how safely and effectively each device prevents complications.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Germany